Bruehlman Ronald E has filed 19 insider transactions across 2 companies since February 2024.
Most recent transaction: a tax payment of 6801 shares of IQVIA HOLDINGS INC. ($IQV) on February 08, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 8, 2026 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | F | Common Stock | 6801 | $187.49 | 55,996.0000 | 259,100,000 | 10.83% | 0.00% |
| Feb. 8, 2026 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | A | Common Stock | 16335 | $0.00 | 62,797.0000 | 259,100,000 | 35.16% | 0.01% |
| Jan. 1, 2026 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | A | Class A Common Stock | 18251 | $0.00 | 129,276.0000 | 361,423,000 | 16.44% | 0.01% |
| Nov. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | M | Class A Common Stock | 21691 | $0.00 | 111,025.0000 | 361,423,000 | 24.28% | 0.01% |
| Nov. 8, 2025 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | M | Deferred Stock Unit | 21691 | $0.00 | 43,384.0000 | 361,423,000 | 33.33% | 0.01% |
| June 3, 2025 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | A | Class A Common Stock | 57050 | $0.00 | 89,334.0000 | 392,172,000 | 176.71% | 0.01% |
| Feb. 10, 2025 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | F | Common Stock | 907 | $206.97 | 46,462.0000 | 258,200,000 | 1.91% | 0.00% |
| Jan. 28, 2025 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | F | Common Stock | 2201 | $203.43 | 47,369.0000 | 258,200,000 | 4.44% | 0.00% |
| Jan. 28, 2025 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | A | Stock Appreciation Right | 31603 | $0.00 | 31,603.0000 | 258,200,000 | 9999.99% | 0.01% |
| Jan. 28, 2025 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | A | Common Stock | 6286 | $0.00 | 49,570.0000 | 258,200,000 | 14.52% | 0.00% |
| Jan. 1, 2025 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | A | Class A Common Stock | 10653 | $0.00 | 32,284.0000 | 392,172,000 | 49.25% | 0.00% |
| Nov. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | A | Class A Common Stock | 1128 | $0.00 | 1,128.0000 | 393,477,000 | 9999.99% | 0.00% |
| Nov. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | A | Deferred Stock Unit | 65075 | $0.00 | 65,075.0000 | 393,477,000 | 9999.99% | 0.02% |
| Nov. 8, 2024 | GoodRx Holdings, Inc. | $GDRX | Bruehlman Ronald E | Director | A | Class A Common Stock | 20503 | $0.00 | 21,631.0000 | 393,477,000 | 1817.64% | 0.01% |
| Feb. 9, 2024 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | F | Common Stock | 1033 | $218.20 | 44,191.0000 | 257,200,000 | 2.28% | 0.00% |
| Feb. 10, 2024 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | F | Common Stock | 907 | $218.20 | 43,284.0000 | 257,200,000 | 2.05% | 0.00% |
| Feb. 7, 2024 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | A | Stock Appreciation Right | 20719 | $0.00 | 20,719.0000 | 257,200,000 | 9999.99% | 0.01% |
| Feb. 6, 2024 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | F | Common Stock | 10514 | $215.41 | 45,224.0000 | 257,200,000 | 18.86% | 0.00% |
| Feb. 6, 2024 | IQVIA HOLDINGS INC. | $IQV | Bruehlman Ronald E | See Remarks | A | Common Stock | 24141 | $0.00 | 55,738.0000 | 257,200,000 | 76.40% | 0.01% |